BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 349551)

  • 1. [Use of antikinin preparations as pathogenetic agents in the overall therapy of tuberculosis].
    Makinskiĭ AI
    Probl Tuberk; 1978 Apr; (4):70-4. PubMed ID: 349551
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of action of the antikinin preparation pyridinolcarbamate on the development of experimental tuberculosis].
    Makinskiĭ AI; Solov'eva IP; Braude VI
    Probl Tuberk; 1984 May; (5):60-5. PubMed ID: 6739480
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of the antikinin preparation prodectin in the complex treatment of pulmonary tuberculosis patients].
    Keleberda KIa; Svistunova AS; Kaminskaia GO; Kordonskaia VM
    Probl Tuberk; 1982 Oct; (10):42-5. PubMed ID: 7178102
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indications for using antikinin preparations and blood kinin system activators in the combined treatment of pulmonary tuberculosis].
    Makinskiĭ AI
    Probl Tuberk; 1981 Oct; (10):33-7. PubMed ID: 7312848
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of antikallikrein-antikinin preparations in emergency therapy].
    Tkachenko EI
    Voen Med Zh; 1989 Sep; (9):31-2. PubMed ID: 2596045
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of parmidin on the course of tuberculosis under isoniazid therapy].
    Solov'eva IP; Makinskiĭ AI
    Vrach Delo; 1984 Sep; (9):70-3. PubMed ID: 6390963
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the kinin system components and structure of the myocardium under the influence of antikinin preparations in allergic myocarditis in rabbits].
    Surovikina MS; Odinokova VA; Paleev NR; Gurevich MA; Iankovskaia MO
    Biull Eksp Biol Med; 1976 Aug; 82(8):979-81. PubMed ID: 193594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of antikinin agents on the course of experimental myocarditis].
    Surovikina MS; Odinokova VA; Paleev NR; Gurevich MA; Iankovskaia MO
    Kardiologiia; 1976 Sep; 16(9):84-9. PubMed ID: 189119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of prodectin in pulmonary tuberculosis].
    Safarov RN; Makinskiĭ AI
    Vrach Delo; 1981 Nov; (11):83-4. PubMed ID: 7342450
    [No Abstract]   [Full Text] [Related]  

  • 10. [Regulation of the activity of the blood kinin system as a method for the pathogenetic therapy of pulmonary tuberculosis].
    Priĭmak AA; Makinskiĭ AI
    Vrach Delo; 1985 Oct; (10):95-7. PubMed ID: 3841435
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of natural protease inhibitors on hemostasis and serum proteolysis blockers in patients with pulmonary tuberculosis].
    Morozova TI; Khudzik LB
    Probl Tuberk; 1993; (3):27-30. PubMed ID: 7527148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Theoretical grounds of a trend of pathogenetic therapy of tuberculosis].
    Puzik VI; Makinskiĭ AI
    Probl Tuberk; 1976 Sep; (9):57-63. PubMed ID: 64980
    [No Abstract]   [Full Text] [Related]  

  • 13. [Feasibility of pathogenetic treatment of pulmonary tuberculosis patients with and without complicating diseases].
    Keleberda KIa; Khudiakova RV; Svistunova AS; Ashirov AA
    Probl Tuberk; 1983 Apr; (4):20-5. PubMed ID: 6866963
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood proteolytic systems in patients with pulmonary tuberculosis].
    Khudzik LB; Morozova TI
    Probl Tuberk; 1994; (5):56-8. PubMed ID: 7870735
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of pyridinolcarbamate in the overall treatment of infiltrative and cavernous-fibrous pulmonary tuberculosis].
    Makinskiĭ AI; Safarov RN; Fondaminskaia LD; Semenova AS; Fedotova NN
    Probl Tuberk; 1979 Jan; (1):26-30. PubMed ID: 368764
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on antiphlogistic effects of fibrinolysin inhibitors].
    Feyen H; Nissen H; Rasche H; Hiemeyer V
    Z Rheumaforsch; 1970; 29(9):276-86. PubMed ID: 4394179
    [No Abstract]   [Full Text] [Related]  

  • 17. [Activity of proteolytic enzymes and their inhibitors in the pulmonary tissue of guinea pigs developing experimental tuberculosis].
    Zhukova NL; Gedymin LE
    Probl Tuberk; 1986; (9):54-8. PubMed ID: 2431409
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of kinin system inhibitors and stimulants on the course of tuberculosis and the healing processes in an experiment].
    Puzik VI; Uvarova OA; Zemskova ZS; Kaminskaia GO; Gedymin LE
    Probl Tuberk; 1983 May; (5):52-6. PubMed ID: 6191323
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antagonism of parmidin to kinin effects].
    Shvarts GIa; Faermark IF; Siubaev RD
    Farmakol Toksikol; 1985; 48(6):37-41. PubMed ID: 4085627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of kininotropic preparations on ulcer formation in rats].
    Faermerk IF; Shvarts GIa
    Farmakol Toksikol; 1988; 51(2):82-4. PubMed ID: 2454203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.